InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Ware Olivia C, Director. Director active across 2 companies, notably Revance Therapeutics, Inc.. Cumulatively, 8 filings have been published. Activity tracked since 5 May 2021. The latest transaction was disclosed on 4 February 2025 (U). Regulator: SEC (Form 4). All data is free.
Declarations8 total
16,675 shares@ US$3.65100.0% of flowCommon StockSEC:0000950170-25-015354:0
15,000 shares0Common StockSEC:0001479290-24-000090:0
9,402 shares@ US$7.6151.7% of flowCommon StockSEC:0001415889-24-011120:0
9,000 shares@ US$7.6148.3% of flowCommon StockSEC:0001415889-24-008340:0
3,534 shares0Common StockSEC:0001479290-23-000063:0
6,059 shares0Common StockSEC:0001479290-22-000058:0
674 shares0Common StockSEC:0001479290-21-000118
674 shares0Common StockSEC:0001479290-21-000118:0
8 of 8 declarations
About Ware Olivia C
Olivia C. Ware serves as a Director of Revance Therapeutics, Inc. In this role, she participates in the governance of the company and in making strategic decisions. Her experience in the biopharmaceutical sector is an asset for Revance in its innovation efforts.
